Use of anxiety-screening questionnaires in patients needing intravitreal anti-VEGF injections may help to identify individuals at risk for elevated pain during the procedure, according to research presented at ARVO 2020.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times